How many insider trades does FilingIQ track for NMTC?

FilingIQ tracks 182 Form 4 insider transactions for NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp), covering filings from Mar 1, 2018 onwards. 21 of those were filed in the last 90 days.

Are NMTC insiders net buyers or net sellers?

Across the full Form 4 history for NMTC, 9 transactions (5%) were open-market purchases and 26 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NMTC insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NMTC in?

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $34.89M.

NMTC insider trading

NasdaqCM Healthcare

NEUROONE MEDICAL TECHNOLOGIES Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

182

Last 90 days

Buys / sells

5% / 14%

Market cap

$34.89M

About NEUROONE MEDICAL TECHNOLOGIES Corp

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company is based in Eden Prairie, Minnesota.

Company website: nmtc1.com

NMTC insider activity at a glance

FilingIQ has scored 182 insider transactions for NMTC since Mar 1, 2018. The most recent filing in our index is dated Apr 3, 2026.

Across the full history, 9 open-market purchases and 26 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NMTC insider trades is 53.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NMTC trades on FilingIQ Raw filings on SEC EDGAR

Latest NMTC Form 4 filings

McClurg Ronald W. Chief Financial Officer

P Apr 4, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for NMTC?: FilingIQ tracks 182 Form 4 insider transactions for NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp), covering filings from Mar 1, 2018 onwards. 21 of those were filed in the last 90 days.
Are NMTC insiders net buyers or net sellers?: Across the full Form 4 history for NMTC, 9 transactions (5%) were open-market purchases and 26 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NMTC insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NMTC in?: NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $34.89M.

Methodology & sources

Every NMTC insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.